Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
6.28
+2.08 (49.40%)
At close: Mar 9, 2026, 4:00 PM EDT
6.60
+0.32 (5.18%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Camp4 Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -80.4 | -51.79 | -49.29 | -44.19 |
| Depreciation & Amortization | 1.64 | 1.7 | 1.68 | 0.88 |
| Loss (Gain) From Sale of Assets | 0.26 | - | - | - |
| Asset Writedown & Restructuring Costs | 0.49 | - | - | - |
| Stock-Based Compensation | 4 | 4.03 | 2.91 | 1.38 |
| Other Operating Activities | 31.45 | 1.83 | 1.82 | 1.69 |
| Change in Accounts Payable | -1.03 | 0.17 | -1.12 | 1.33 |
| Change in Unearned Revenue | 17.12 | 0.39 | - | - |
| Change in Other Net Operating Assets | -3.08 | -1.88 | -0.15 | 0.37 |
| Operating Cash Flow | -29.55 | -45.56 | -44.16 | -38.54 |
| Capital Expenditures | -0.28 | -0.44 | -0.68 | -4.03 |
| Sale of Property, Plant & Equipment | 0.04 | - | - | - |
| Investing Cash Flow | -0.24 | -0.44 | -0.68 | -4.03 |
| Long-Term Debt Issued | - | - | 0.71 | - |
| Long-Term Debt Repaid | -0.21 | -0.82 | -0.59 | -0.09 |
| Net Debt Issued (Repaid) | -0.21 | -0.82 | 0.12 | -0.09 |
| Issuance of Common Stock | 57.57 | 76.47 | 0.19 | 0.06 |
| Other Financing Activities | 18.53 | -3.98 | - | - |
| Financing Cash Flow | 75.89 | 71.66 | 0.3 | 100.16 |
| Net Cash Flow | 46.09 | 25.66 | -44.53 | 57.59 |
| Free Cash Flow | -29.83 | -46 | -44.83 | -42.57 |
| Free Cash Flow Margin | -852.83% | -7055.67% | -12809.43% | - |
| Free Cash Flow Per Share | -0.98 | -9.81 | -113.51 | -136.31 |
| Levered Free Cash Flow | -20.64 | -26.52 | -30.18 | - |
| Unlevered Free Cash Flow | -20.64 | -26.52 | -30.16 | - |
| Change in Working Capital | 13.01 | -1.33 | -1.27 | 1.7 |
Source: S&P Capital IQ. Standard template.
Financial Sources.